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Background: Several alternatively-spliced mRNA transcripts of the follicle stimulating hormone receptor (FSHR) have
been identified in sheep, including FSHR-1 (G protein-coupled form), FSHR-2 (dominant negative form), and FSHR-3
(growth factor type-1 form). Our objective was to determine which of these variants is predominantly expressed in
follicles collected from ewes at various times after estrus.
Methods: Suffolk-cross ewes (n = 8) were allowed to come into estrus naturally and were euthanized 24 (n = 3),
36 (n = 3), or 48 (n = 2) hours after the onset of estrus. All visible follicles were measured, aspirated and pooled
according to follicular diameter: small (<= 2.0 mm), medium (2.1-4.0 mm), large (4.1-6.0 mm), and preovulatory
(> = 6.1 mm). Aspirated cells were separated from follicular fluid by centrifugation. Total RNA was extracted from
cell pellets and reverse transcribed. The resulting cDNA was subjected to qPCR, using primer sets designed to
amplify each variant specifically. Gene expression was normalized to that of beta–actin within samples, and
compared by analysis of variance with the level of significant differences set at p < .05.
Results: Relative expression of FSHR-3 exceeded that of both FSHR-1 and FSHR-2 in medium follicles, and tended
to be higher in small follicles (p = .09) regardless of time after onset of estrus, and thus results from different time
points were pooled. Expression of FSHR-3 was greater than that of FSHR-2 and luteinizing hormone receptor (LHR)
in small and medium follicles. Expression of LHR was greatest in preovulatory follicles.
Conclusions: These experiments show that in addition to the well characterized G protein-coupled form of the
FSHR, alternatively spliced variants of the FSHR may participate in follicular dynamics during follicular waves of the
sheep estrous cycle. Furthermore, these results indicate that an “alternatively” spliced form of the FSHR (FSHR-3) is
the predominant form of the FSHR in the sheep.
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For successful reproduction to occur, follicles must
develop through several stages within the ovary. Antral
follicle growth is regulated largely by follicle stimulating
hormone (FSH) and luteinizing hormone (LH) from the
pituitary. In order for FSH and LH to exert their effects,
the appropriate receptors must be present on follicular
cells at the correct time. At least one form of the follicle
stimulating hormone receptor (FSHR) is detectable soon
after follicle formation in sheep [1]. Several alternatively
spliced FSHR mRNA variants have been identified in
sheep [1-4]. Each splice variant has a unique exon* Correspondence: trozell@k-state.edu
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reproduction in any medium, provided the orstructure that may dictate receptor coupling to signaling
molecules.
Messenger RNA for the G protein-coupled form of the
FSHR (FSHR-1) was first sequenced and described in
the rat in 1990 [5] and in the sheep in 1993 [2]. Sheep
FSHR-1 mRNA is 2431 base pairs (bp) in length, and
consists of 10 exons. Once translated, FSHR-1 is capable
of activating several intracellular signaling pathways, but
cAMP/PKA is the most commonly described pathway
(as reviewed by [6]). The FSHR-1 form is important for
granulosa cell (GC) differentiation and hormone produc-
tion, as well as GC proliferation (as reviewed by [7]).
Other identified splice variants include FSHR-2 (domin-
ant negative receptor) and FSHR-3 (growth factor type-1l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of FSHR-1, except that FSHR-2 has a truncated exon 10
spliced to exon 11 [4]. The truncation in exon 10 is
thought to affect receptor signaling, potentially by altering
the intracellular portions of the receptor [4]. Although
FSHR-2 has been shown to bind FSH with high affinity,
downstream signaling did not occur [8]. In fact, when
FSHR-2 and FSHR-1 were co-transfected into HEK 293
cells and treated with FSH, only a very small increase in
intracellular cAMP was detectable, in contrast to the large
increase caused by cells expressing FSHR-1 alone. Thus,
FSHR-2 appeared to attenuate the actions of FSHR-1,
leading the authors to conclude that FSHR-2 acts as a
dominant negative form of the FSHR [8].
Exons 1–8 encoding FSHR-3 are identical to that of
FSHR-1; however, FSHR-3 lacks exons 9 and 10, and the
first 8 exons are spliced directly to exon 11 [3,9]. In con-
trast to FSHR-1, FSHR-3 may act in a cAMP-independent
fashion. When stimulated by FSH, it has been shown
to activate a mitogen-activated protein kinase (MAPK)
pathway, specifically the extracellular-regulated kinase
(ERK) signaling cascade [10]. The ERK cascade is in-
volved in cell proliferation, is regulated by Ras and is
regulated by a Ca2+ dependent process. When Touyz
et al. [11] transfected HEK 293 cells with FSHR-3,
treatment with FSH resulted in a dramatic increase in
Ca2±. The significance of these findings relates to the
increases in cell proliferation observed shortly after
calcium influx and activation of the ERK signaling cas-
cade [11]. These studies provide possible evidence that
FSH can stimulate granulosa cell proliferation directly
through FSHR-3.
In the cow, FSHR transcripts containing exon 11
(FSHR-2 or FSHR-3) were more highly expressed in co-
hort than in dominant follicles [12]. However, FSHR
transcripts containing exon 10 (FSHR-1) were more
highly expressed in cohort and dominant follicles than
in subordinate follicles during the estrous cycle [12].
Based on those findings we postulated that alternative
FSHR transcripts, in addition to the well characterized
FSHR-1 form, may be expressed differently in differently
sized follicles under normal physiological conditions in
the ewe.
Methods
Animals and sample collection
All animal procedures were approved by the Kansas
State University Animal Care and Use Committee
(IACUC protocol #2735). Ewes were group housed at
the KSU Sheep Unit in a south-facing lean-to barn and
were exposed to natural lighting and temperature (39°
12′ 22″ N, 96° 35′ 12″ W). Ewes had free access to
water and were fed a maintenance diet of grass hay and
2 pounds/head/day of a grain supplement (87% DM;14% CP; 85% TDN). Ewes were transported from the
KSU Sheep Unit to the KSU Diagnostic Lab for euthan-
asia. When ewes were loaded onto the trailer, blood
samples were collected via jugular venipuncture and
placed on ice until refrigeration at 4°C for 24 hours.
Serum was separated by centrifugation at 1500×g for
20 minutes at 4°C. Serum was decanted into a 5 ml poly-
propylene tube, capped and stored at −20°C until assay.
Time from loading ewes to euthanasia was less than
1 hour. Ewes were euthanized by intravenous overdose
(90 mg/kg) of sodium pentobarbital.
Eight mature cycling (2–8 years of age) Suffolk-cross
ewes were allowed to come into estrus naturally. Estrous
cycle length was monitored using a HeatWatch® detection
system (Denver, CO) and two vasectomized rams through
3 consecutive cycles before harvesting ovaries at the
end of the breeding season in late January through early
February. Onset of estrus was defined as the beginning
of the period that a ewe was receptive to mounting by
the ram. After a HeatWatch® transmitter was activated
by a ram, estrous behavior was visually confirmed. Ewes
were euthanized 24 (n = 3), 36 (n = 3), or 48 (n = 2)
hours after onset of estrus. Ovaries were harvested and
placed on ice before transport to the laboratory for
evaluation. Left and right ovaries of each ewe were kept
separate until photographed and all ovarian structures
were measured (to the nearest 0.5 mm) and recorded.
Ovarian structures were measured with a transparent
ruler from the external surface of the ovary. All visible
follicles were aspirated using 1 cc syringes and 20 gauge
needles. Each follicle was aspirated such that the needle
was inserted, follicular fluid was pulled into the syringe
and then gently pushed back into the same follicle three
times before removing the needle and moving to the next
follicle. A new syringe and needle were used for each ewe
and each follicle size class. Aspirates were pooled in 1.5 ml
microcentrifuge tubes according to follicular diameter:
small (≤ 2.0 mm), medium (2.1-4.0 mm), large (4.1-
6.0 mm) and preovulatory (≥ 6.1 mm). Follicular fluid
and aspirated cells (should be primarily granulosa cells,
but the presence of thecal cells within the pellet was not
determined) were separated by centrifugation at room
temperature for two minutes at 2300×g. Follicular fluid
was removed and stored at −20°C for estrogen and pro-
gesterone assays.
Cell pellets were resuspended in 500 μl ice-cold Dulbec-
co’s Phosphate Buffered Saline (PBS; Invitrogen, Carlsbad,
CA) and centrifuged at room temperature for one minute
at 2300×g. The PBS was aspirated and discarded and the
cell pellets were resuspended in 1 ml TRIzol® reagent (Life
Technologies, Grand Island, NY) and frozen at −20°C
until all samples were collected. Time between ovary har-
vest and placing cells in TRIzol® reagent did not exceed
2 hours.
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RNA was isolated from samples using TRIzol® reagent
according to the manufacturer’s instructions. The RNA
pellet was washed with 75% EtOH and resuspended in
15 μl preheated (65°C) nuclease-free water (Ambion®,
Austin, TX). All RNA extracts were treated with TURBO
DNA-free™ (DNase; Ambion®) according to the manufac-
turer’s instructions to remove any genomic or other cel-
lular DNA and stored at −20°C.
Reverse transcription – polymerase chain reaction
Total RNA (100 ng) was used as the starting template
for RT-PCR. Some samples with low (≤ 50 ng/μl) con-
centrations of total RNA initially failed to produce con-
sistent real-time PCR products. Total RNA from those
samples was then reverse-transcribed using 200 or
300 ng total RNA to ultimately ensure adequate tem-
plate for real time PCR. Total RNA was reverse-
transcribed using SuperScript™ III First-Strand Synthesis
SuperMix (Invitrogen), according to the manufacturer’s
instructions. Conditions were as follows for reverse
transcription: 25°C hold for 25 minutes, 42°C for 50 mi-
nutes, 85°C for 5 minutes. At the end of the reverse-
transcription reaction, samples were placed on ice for at
least 1 minute. To remove template RNA, 1 μl RNase H
was added to each sample and samples were incubated
at 37°C for 20 minutes. Reactions were stored at −20°C
until used for qPCR.
Real-time PCR
Real-time PCR was performed using an ABI 7500 Fast
machine (Applied Biosystems, Foster City, CA) with the
following parameters: 50°C for 2 min, 95°C for 2 min
followed by 40 cycles of: 95°C for 15 sec, 60°C for
30 sec. Platinum® SYBR® Green qPCR SuperMix-UDG
(Invitrogen™) was used at 10 μl per well; forward and re-
verse primers were used at 250 nM concentrations,
cDNA template was diluted in 5 μl total volume using
nuclease-free water, and nuclease-free water was used toTable 1 Description of primers used for quantitative real-time
Target Accession no. Primer name Seq
β -Actin NM_001009784 oBeta-Actin For GTC
oBeta-Actin Rev CGT
FSHR-1 L07302 oExon10 For CAT
oExon10 Rev TGA
FSHR-2 NM_001009289 oExon10/11 For CAG
oExon10/11 Rev TGA
FSHR-3 L12767 oExon8/11 For CAG
oExon8/11 Rev AAC
LHR L36329 oLHR For AGA
oLHR Rev GCAbring the final reaction volume to 20 μl. Melt-curve ana-
lysis was performed on all samples after amplification,
by heating products to 95°C and plotting the derivative
of the reporter (fluorescence) and temperature at which
products denature. All primers were designed using
Primer Express® 3.0 software (Applied Biosystems) and
synthesized by Applied Biosystems. Expression of β-actin
was used as an internal standard. Primers (Table 1) used
to detect FSHR-1, FSHR-2, FSHR-3 and LHR were de-
signed to amplify each variant specifically (Figure 1), based
on unique exon boundaries and were developed from sub-
mitted nucleotide sequences of each variant as referenced
in Table 1.
Primer efficiencies ranged from 85 to 100%. Primer
efficiencies under 95% were corrected to 100% so that
comparisons between genes could be made.
Radioimmunoassay
Duplicate aliquots (50 μl) of serum were assayed for
progesterone concentration, as described and validated
previously [13]. Sensitivity of the assay was 3.5 pg/tube
and the mean intra- and inter-assay coefficients of vari-
ation (CV) were 4.75% and 4.55%, respectively. Duplicate
aliquots (200 μl total volume) of follicular fluid were
assayed without extraction for estradiol and progesterone,
using previously described and validated assays [14,15].
Briefly, for estradiol evaluation, follicular fluid from small
and medium-sized follicles was diluted 1:100 and follicular
fluid from preovulatory follicles was diluted 1:500 prior
to assay. Estradiol concentration was determined using
a double antibody kit (Siemens Medical Solutions Diag-
nostics; Deerfield, IL). Sensitivity of the assay was
0.02 pg/tube and the mean intra-assay CV was 1.6%.
Progesterone concentrations were determined using
Coat-A-Count antibody coated tubes from Siemens
Medical Solutions Diagnostics. For progesterone evalu-
ation, follicular fluid from all follicle sizes was diluted
1:50. Sensitivity of the assay was 0.012 ng/tube and the
mean intra-assay CV was 9.35%.PCR
uence 5’ to 3’ Length Amplicon
ATCACCATCGGCAATGA 20 88
GAATGCCGCAGGATT 18
TCACTGCCCACAACTTTCATC 24 84
GTGTGTAATTGGAACCATTGGT 25
GAACTTCCGCAGGGATT 20 72
TTGCAGATGAGCCCAACA 21
TAATTTGGAAGAACTGCCTAATG 26 80
AGTGCAGCAGTGGAGACA 21
TTGCTAAGAAAATGGCAGTCCTCT 28 82
GCTGAGATGGCAAAGAAAGAGA 25
Figure 1 Location of primers to specifically amplify FSH
receptor splice variants. Primer pairs used for real time PCR were
designed to result in amplicons unique to each specific form of the
receptor as follows: FSHR-1—primer annealing sites within the unique
region of exon 10 only found in this variant form of the receptor;
FSHR-2—upstream primer annealing sites overlapping the exon 10
and 11 boundary only found in this variant; FSHR-3—upstream primer
annealing sites overlapping the exon 8 and 11 boundary only found in
this variant. Predicted sizes of amplicons were verified on an agarose
gel (not shown), and melt curve analysis was performed to verify
single products.
Figure 2 Expression of gonadotropin receptors within different
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Relative expression (2.0-ΔCt × 1000) values were used
for statistical analysis of real-time PCR data. Data were
analyzed with SAS 9.1 software (SAS Institute, Cary,
NC) using Proc Mixed and least squared means. The
experiment had a completely randomized design with a
split-plot, with the split-plot having treatments in a 2
(follicle size) × 4 (gene) factorial. The ANOVA models
included all treatment factor main effects and interac-
tions; ewe was included as a random effect. Normality
of residuals was tested and data transformed if necessary.
The whole-plot treatment factor is hour and experimental
unit is ewe. Gene expression in preovulatory follicles was
analyzed separately because this size was only present in
the 24-hour group. Untransformed data are presented as
least squares means of relative expression ± SEM. After
least squared means were calculated, they were back-
transformed (by exponentially raising the transformed
mean values). Confidence intervals for the transformed
means were calculated so new standard errors could be
assigned. Back-transformed data are presented as least
squares means of relative expression, ± SEM.sized sheep follicles. Cells were collected by centrifugation from
follicular fluid aspirated from small (≤ 2.0 mm), medium (2.1-4.0 mm)
and preovulatory (≥ 6.1 mm; *only found in the 24 hour group)
follicles. Results from real time PCR are expressed as least squares
means of expression relative to β-actin (2-ΔCt ×1000; arbitrary
units) ± SEM. Bars within graphs with differing superscripts are different
(p < .05). Expression of FSHR-1 (white bars), FSHR-2 (light gray bars),
FSHR-3 (dark gray bars), and LHR (black bars) are compared within a
follicle size class. Panel A) Relative expression of FSHR-3 was higher
than FSHR-2 and LHR, and tended to be higher than FSHR-1
(*p = .09) in small follicles. Panel B) Relative expression of FSHR-3
was higher than other variants and LHR in medium follicles. Relative
abundance of mRNA for FSHR-1 and FSHR-2 did not differ, but both
were more highly expressed than LHR. Panel C) Relative expression
of LHR was the highest in preovulatory follicles, while FSHR-1,
FSHR-2, and FSHR-3 did not differ.Results
Ewes were euthanized at 24 (n = 3), 36 (n = 3) or 48 (n = 2)
hours after onset of estrus. Expression of FSHR variant and
LHR mRNA were not found to be different at the different
time points (p > .05), and thus the following results are
mean expression of genes from follicles collected within
all time points. When comparing all FSHR variants and
LHR within a follicle class size, FSHR-3 was more highly
expressed than FSHR-1 in medium follicles (p < .05;
Figure 2), and tended to be higher in small follicles
(p = .09). Relative expression of FSHR-3 was higher than
FSHR-2 in small and medium follicles (p < .05; Figure 2,
panels A and B). In preovulatory follicles, LHR expression
increased dramatically and was higher than all FSHR
variants (p < .05); expression of FSHR variants was
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(Figure 2, panel C).
When comparing expression of each variant between
small and medium follicles (Figure 3), neither FSHR-1
nor FSHR-2 was differentially expressed (p = 0.34 and
0.42, respectively); however, FSHR-3 expression was
higher in medium than in small follicles (p < .05). Relative
expression of LHR was essentially undetectable in small
follicles and very low, on average, in medium follicles
(p = .85).
Follicular fluid estrogen and progesterone concentra-
tions were determined using RIA. Estradiol concentrations
were consistently lower than progesterone (Figure 4); con-
sequently, only one sample had an estradiol:progesterone
ratio that exceeded 1.0. That sample, (Ewe 4, 48 hour; n = 3
medium follicles) had an E:P ratio of 2.0 and could
therefore be considered a pool of healthy follicles, at
least on average.
Estradiol concentrations from small follicle pools aver-
aged 0.77 ng/ml and ranged from 0.07 ng/ml to 2.26 ng/
ml. Estradiol concentrations for medium follicles averaged
2.53 ng/ml with a range from 0.05 ng/ml to 13.60 ng/ml).
Estradiol in preovulatory follicles averaged 3.18 ng/ml.
Preovulatory follicles were only present in the 24 hour
group, with Ewe 12 (24 hour; n = 2 follicles) having the
lowest (0.91 ng/ml) estradiol concentration and Ewe 16
(24 hour; n = 2 follicles) having the highest (7.28 ng/ml)Figure 3 Expression of gonadotropin receptors across different sized
aspirated from small (≤ 2.0 mm; white bars) or medium (2.1-4.0 mm; gray b
means of expression relative to β-actin (2-ΔCt ×1000; arbitrary units) ± SEM
Panels A), B), and D) Relative expression of FSHR-1, FSHR-2, and LHR did n
expression of FSHR-3 was higher in medium than small follicles. Overall, FS
and medium follicles.concentration. Mean progesterone concentration in
small follicles was 7.61 ng/ml and ranged from 1.61—
10.97 ng/ml. Progesterone concentration in medium
follicles averaged 4.18 ng/ml and ranged from 1.38—
7.21 ng/ml. Preovulatory follicles had the highest mean
progesterone concentration at 66.74 ng/ml, ranging
from 43.70—90.29 ng/ml.
The E:P ratio was compared to relative gene expression
of each transcript. Correlation values for for E:P ratio with
gene expression are shown in Figure 5. Correlation be-
tween E:P and expression was the highest for FSHR-2 in
small follicles (R = 0.4), although FSHR-2 was still the
least expressed transcript. In medium follicles, the highest
correlation was between E:P and LHR (R = 0.51).
Serum progesterone concentrations were evaluated
from blood samples taken when ewes were loaded for
transport. Serum progesterone values ranged from 0.35 -
0.67 ng/ml (Table 2).
Estrous cycle lengths of ewes were similar (Table 2)
except for one ewe: Ewe 4 exhibited shorter cycles that
averaged 8.25 days. Relative expression of FSHR variants
within samples collected from Ewe 4 fell in the range of
ewes with normal cycle length; as such, those results
were included. The average number of follicles found
per group are listed in Table 2.
Follicle totals (Table 2) were as follows: small (≤ 2.0 mm;
n = 109 total; n = 8 pools), medium (2.1 – 4.0 mm; n = 54follicles. Cells were collected by centrifugation from follicular fluid
ars) follicles. Results from real time PCR are expressed as least squares
. Bars within graphs with differing superscripts are different (p < 0.05).
ot significantly differ in small versus medium follicles. Panel C) Relative
HR-3 expression was the only transcript that differed between small
Figure 4 Estradiol and progesterone concentrations in follicular
fluid from different-sized sheep follicles. Follicular fluid was
pooled according to follicle diameter: small (≤ 2.0 mm), medium
(2.1-4.0 mm) and preovulatory (preov; ≥ 6.1 mm). After cells were
separated by centrifugation, duplicate aliquots (200 μl total volume)
of follicular fluid were analyzed by RIA without extraction.
Progesterone concentrations were consistently higher than estradiol
in small, medium and preovulatory follicular fluid pools. Data are
expressed as mean ± SEM.
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tory (≥ 6.1 mm; n = 7 total; n = 3 pools). No large follicles
were analyzed for RNA expression due to sampling errors
and/or lack of GC recovery during aspiration. No signifi-
cant differences were found between collection times
(24, 36, or 48 hours after onset of estrus) for number of
follicles within a size class.Figure 5 Correlation between estradiol to progesterone ratio
and gene expression in small and medium sheep follicles.
Follicular fluid was pooled according to follicle diameter: small
(≤ 2.0 mm) and medium (2.1-4.0 mm). After cells were separated by
centrifugation, duplicate aliquots (200 μl total volume) of follicular
fluid were analyzed by RIA without extraction. Estradiol and
progesterone concentrations were determined for each sample, and
the ratio of estradiol to progesterone was calculated, then analyzed
for correlation to FSHR or LHR gene expression. The FSHR-2 variant
had the highest correlation (R = 0.4) to the E:P ratio compared to
other FSHR variants. The E:P was inversely correlated to LHR expression
in small follicles (R = −0.41), and FSHR-1 expression in medium follicles
(R = −0.41). Data are expressed as correlation (R) values.Discussion
We have shown that in untreated mature ewes allowed
to cycle naturally, the relative expression of FSHR-3 was
greater than FSHR-1 in cells collected from medium
(2.1-4.0 mm) follicles and tended to be higher in cells
collected from small follicles. These results provide the
first evidence that FSHR-3 is not a rare transcript in
sheep. Based on its structure, the FSHR-3 variant has been
described to function as a growth factor type-I receptor
for FSH through activation of the extracellular-regulated
kinase (ERK) pathway in granulosa cells [10]. Regardless
of follicle size, FSHR-3 expression appeared to exceed that
of FSHR-1, indicating that FSHR-3 may be more im-
portant during follicular development in the ewe than
previously thought. Expression of LHR was expected to
increase with increasing granulosa cell differentiation
(and follicle diameter) [16-18] and this was the case in
the present experiment. Relative expression of FSHR-2
was the lowest of all FSHR variants, with expression
only exceeding (although not significantly) that of FSHR-1
in preovulatory follicles.
The G protein-coupled form of the FSH receptor,
FSHR-1 appeared to be expressed in follicles of all sizes
at 24, 36, and 48 hours after the onset of estrus. These
results agree with Tisdall et al. [1] who found FSHR to
be expressed in follicles as small as the primary stage,
with expression continuing thereafter, even in follicles
beginning to undergo atresia [1]. However, Abdennebi
et al. [16] and many others have attempted to assess
FSHR expression using primers or probes that would
not discriminate between the different FSHR variants,
and thus it is not possible to determine which form of
the FSHR was present, or to predict second messenger
pathways used by FSH at different stages of follicular
development. In the current study, care was taken to
design primers such that specific variants of the FSHR
would be discernable (Figure 1).
Other studies have been conducted that examined
FSHR variant expression in both sheep and mice using
RT-PCR and Western blotting. In one study, immature
mice (21d) were PMSG- primed (5 IU) and ovaries were
harvested 24 or 48 hours later [19]. A two-fold increase
was seen in FSHR-3 expression over FSHR-1 in PMSG-
primed mice; a corresponding increase in each receptor
protein expression was also observed. McNatty et al.
[20] showed that PMSG (500 IU) priming can decrease
atresia of small antral follicles during luteolysis in sheep.
These investigators also saw that at 24 hours, the pro-
portion of healthy and atretic follicles was restored to
pretreatment levels [20]. Thus, because the effects of
PMSG are relatively short-lived, assessment of FSHR
variant expression within follicles at 12 hours after treat-
ment with PMSG should be considered in the future. In
addition, dose–response experiments using PMSG in
Table 2 Average values for sample collection parameters in experiment 1 and 2
Group Time to euthanasia Mean cycle length Number of follicles Luteal tissue (#) Serum
progesterone
Exp 1 (hours) (days) ≤ 2 mm 2.1-4 mm 4.1-6 mm ≥ 6.1 mm CH CL CA (ng/ml)
24 22.83 ± 0.24 16.31 ± 0.48 11 ± 8.3 5.7 ± 0.7 0 2 ± 0 0 0.3 ± 0.3 2.0 ± 0.6 0.43 ± 0.06
36 36.64 ± 0.83 16.80 ± 0.28 15.7 ± 5.0 8.3 ± 2.7 0.3 ± 0.3 0.3 ± 0.3 1.6 ± 0.3 1.0 ± 0.6 2.0 ± 0.6 0.54 ± 0.14
48 49.33 ± 2.16 13.10 ± 4.85 14.5 ± 2.5 6.0 ± 3.0 0.5 ± 0.5 0 2.5 ± 0.5 1.5 ± 1.5 1.5 ± 0.5 0.55 ± 0.13
Ewes were monitored through three estrous cycles then euthanized 24 (n = 3), 36 (n = 3), or 48 (n = 2) hours after the onset of the next estrus. Data are presented
as means ± SEM. Ovarian structures were measured on the external surface of the ovary with a transparent ruler (to the nearest 0.5 mm) and recorded. All visible
follicles were aspirated and follicular fluid from each pair of ovaries was pooled according to follicular diameter: small (≤ 2.0 mm), medium (2.1-4.0 mm), large
(4.1-6.0 mm; gene expression in large follicles was not assessed due to low cell numbers) and preovulatory (≥ 6.1 mm). Blood was collected immediately prior
to euthanasia.
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sion would need to be performed before conclusions can
be made to determine if PMSG stimulates alterations in
FSHR variant expression in sheep.
To help determine the health of follicles collected in
this experiment, progesterone and estradiol concentra-
tions for follicular pools were examined. Steroid content
of follicular fluid can be used as an indicator of follicular
health status when looking at steroid profiles of individ-
ual follicles [21]. In the current study, follicles were
pooled for each pair of ovaries based on size criteria,
and accordingly, follicular health assessments based on
estradiol and progesterone represented “average” follicle
health and not actual health of each follicle in which
FSHR variants were measured. Nevertheless, “average”
follicle health may provide an initial indication of average
FSHR variant expression based on stage of development.
Because follicles of similar sizes can have very different
steroid profiles [22], assessing follicular health based on
steroid content can be difficult. Results herein were similar
to those of Somchit et al. [23], in that they observed higher
progesterone than estradiol concentrations in pooled fol-
licular fluid from follicles < 3.5 and ≥ 3.5 mm in diameter.
We saw the same trend in pools of fluid from small
(≤ 2.0 mm) or medium (2.1-4.0 mm) follicles. Because
progesterone concentrations were consistently higher than
estradiol, we believe that a greater number of atretic small
or medium follicles were collected than healthy (growing)
small or medium follicles. This is a reasonable assumption
when considering the mechanism of follicular dynamics.
Once follicles reach the preovulatory size, estradiol is no
longer the primary hormone produced by the follicle [21],
so parameters in addition to the E:P ratio are necessary
when assessing follicular health of that follicle size class.
Serum progesterone was measured to help assess cyc-
ling status. Circulating progesterone concentrations
during the luteal phase of ewes are about 3 ng/ml, while
progesterone concentrations during estrus are generally
less than 1 ng/ml [24]. For Experiment 1, progesterone
concentrations collected just prior to euthanasia were
under 1 ng/ml, so any corpora lutea observed when ovar-
ies were examined after harvest were probably regressing.Low serum progesterone concentrations, taken together
with estrous behavior observations, provide compelling
evidence that detection of onset of estrus was accurate.
Conclusions
The diverse actions of FSH on follicles during the estrous
cycle are well documented, and include stimulation of
differentiation, hormone production, and proliferation
of granulosa cells. Some of these actions are mediated
by FSHR-1 through activation of adenylate cyclase and
production of cAMP. The G protein-coupled form of
the receptor can also activate other signaling pathways,
including extracellular regulated kinases (ERKs), and
mitogen-activated protein kinases (MAPKs) [6]. The
identification of the FSHR nucleotide sequence [2,5]
made it possible to detect alternatively spliced variants
of the FSHR [3,8,25]. The finding that FSHR-3 is the
primary form of the FSHR in at least medium sized fol-
licles examined in these experiments supports the idea
that other forms of the FSHR, in addition to the well-
characterized G protein-coupled form, may participate
in follicular growth and development during the sheep
estrous cycle.
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